Provided by Tiger Trade Technology Pte. Ltd.

STARPHARMA HOLDINGS LTD

0.830
+0.0151.84%
Volume:1.87M
Turnover:1.55M
Market Cap:398.18M
PE:-48.82
High:0.845
Open:0.810
Low:0.810
Close:0.815
52wk High:0.875
52wk Low:0.239
Shares:479.74M
Float Shares:347.84M
Volume Ratio:0.65
T/O Rate:0.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.017
EPS(LYR):-0.020
ROE:-45.55%
ROA:-21.00%
PB:28.90
PE(LYR):-41.50

Loading ...

Company Profile

Company Name:
STARPHARMA HOLDINGS LTD
Exchange:
ASX
Establishment Date:
1997
Employees:
50
Office Location:
4-6 Southampton Crescent,Abbotsford,Victoria,Australia
Zip Code:
3067
Fax:
61 3 9510 5955
Introduction:
Starpharma Holdings Limited engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company focuses on the development of VivaGel, which has completed Phase III clinical trials for the management and prevention of bacterial vaginosis, and as a condom coating for the prevention of sexually transmitted infections, as well as VivaGel condom, an antiviral condom. It also develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase 1/2 clinical trial, and DEP irinotecan that is in phase 1/2 clinical trials for the treatment of solid tumors. The company was founded in 1996 and is headquartered in Abbotsford, Australia.